SCHEMBL19905405

SCHEMBL19905405

CNC(=O)c1c(F)cnc2c(CCNc3cc(-c4ccc(C5CCC5)nc4)ncn3)cccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FEN1 P39748 2/20 0.36
FFAR4 Q5NUL3 1/20 0.34
CYP1A2 P05177 7/20 0.34
CYP3A4 P08684 7/20 0.34
CLK4 Q9HAZ1 7/20 0.34
USP2 O75604 6/20 0.34
CYP2C19 P33261 6/20 0.34
CYP2D6 P10635 6/20 0.34
ALDH1A1 P00352 4/20 0.34
ALOX15 P16050 3/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
CYP2C9 P11712 2/20 0.34
HSD17B10 Q99714 3/20 0.34
CHRM1 P11229 1/20 0.33
ALOX5AP P20292 1/20 0.33
CSF1R P07333 1/20 0.33
PIP5K1C O60331 1/20 0.33
FAAH O00519 1/20 0.33
MAPK1 P28482 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19355604 0.97 FFAR4 (0.37) FEN1FFAR4CYP1A2CYP3A4CLK4
SCHEMBL19905355 0.92 CYP1A2 (0.36) FEN1CYP1A2CYP3A4CLK4USP2
SCHEMBL19905429 0.89 CYP1A2 (0.35) CYP1A2CYP3A4CLK4USP2CYP2C19
SCHEMBL19355618 0.89 CYP1A2 (0.37) CYP1A2CYP3A4CLK4USP2CYP2C19
SCHEMBL22838609 0.88 CYP1A2 (0.36) FEN1CYP1A2CYP3A4CLK4USP2
SCHEMBL19905470 0.88 CYP1A2 (0.36) FEN1CYP1A2CYP3A4CLK4USP2
SCHEMBL19355139 0.87 PIP5K1C (0.38) CYP1A2CYP3A4CLK4USP2CYP2C19
SCHEMBL19905266 0.87 PRKDC (0.37) CYP1A2CYP3A4CLK4USP2CYP2C19
SCHEMBL19355532 0.87 CYP1A2 (0.37) FEN1CYP1A2CYP3A4CLK4USP2
SCHEMBL19355152 0.86 KDM4E (0.37) CYP1A2CYP3A4CLK4USP2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3057959-B1 DNA-PK INHIBITORS VERTEX PHARMA (US) 2018-02-28 EP disclosed